Viral hepatitis

Delve into the world of Viral hepatitis in China’s pharmaceutical industry. Fineline Info & Tech provides reliable data, news, and insights on Viral hepatitis to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Atavistik Bio Strikes CVRM Collaboration with Roche – USD 70 Million Upfront, up to USD 1.9 Billion in Milestones for Allosteric Small‑Molecule Discovery
CompanyDeals

Atavistik Bio Strikes CVRM Collaboration with Roche – USD 70 Million Upfront, up to USD 1.9 Billion in Milestones for Allosteric Small‑Molecule Discovery

Atavistik Bio announced a strategic research collaboration with Roche Holding AG (SWX: ROP; OTCMKTS: RHHBY) to discover and develop novel small molecule therapies targeting multiple targets in cardiovascular, renal, and…

HUTCHMED Initiates Phase Ia Global Trial of HMPL-A830 – First‑in‑Class KRAS‑Payload Antibody‑Targeted Conjugate Licensed to GSK for up to USD 1.295 Billio

HUTCHMED Initiates Phase Ia Global Trial of HMPL-A830 – First‑in‑Class KRAS‑Payload Antibody‑Targeted Conjugate Licensed to GSK for up to USD 1.295 Billion

FDA Approves AbbVie's Tavapadon as Juvmo for Parkinson's Disease – Once‑Daily Dopamine Mimetic Joins $8.7 Billion Cerevel Portfoli

FDA Approves AbbVie’s Tavapadon as Juvmo for Parkinson’s Disease – Once‑Daily Dopamine Mimetic Joins $8.7 Billion Cerevel Portfolio

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
AusperBio Gains NMPA Approval for Phase III Trials of AHB-137 in Chronic Hepatitis B
CompanyDrug

AusperBio Gains NMPA Approval for Phase III Trials of AHB-137 in Chronic Hepatitis B

Cosunter's GST-HG131 Granted Breakthrough Therapy Designation for HBV Treatment in China
CompanyDrug

Cosunter’s GST-HG131 Granted Breakthrough Therapy Designation for HBV Treatment in China

SCG Cell Therapy Obtains NMPA Approval for SCG101V in Chronic HBV Study
CompanyDrug

SCG Cell Therapy Obtains NMPA Approval for SCG101V in Chronic HBV Study

Fujian Cosunter Gains Ethics Approval for Phase III Study of Neracorvir in CHB Patients
CompanyDrug

Fujian Cosunter Gains Ethics Approval for Phase III Study of Neracorvir in CHB Patients

AbbVie's Mavyret Gains FDA Approval for Acute HCV in Children and Adults
CompanyDrug

AbbVie’s Mavyret Gains FDA Approval for Acute HCV in Children and Adults

Drug Farm and Amoytop Biotech Collaborate on DF-006 for HBV and HCC
CompanyDeals

Drug Farm and Amoytop Biotech Collaborate on DF-006 for HBV and HCC

Gilead Sciences to Acquire Hookipa's HB-400 and HB-500 Vaccine Programs
CompanyDeals

Gilead Sciences to Acquire Hookipa’s HB-400 and HB-500 Vaccine Programs

Hengrui Pharmaceuticals Receives NMPA Clearance for HRS-5635 in Chronic HBV
CompanyDrug

Hengrui Pharmaceuticals Receives NMPA Clearance for HRS-5635 in Chronic HBV

Show More